Prevention of vertigo in Ménière's syndrome by means of transtympanic ventilation tubes.
The insertion of a transtympanic ventilation tube prevented the occurrence of vertiginous attacks in 82% of a series of 28 patients suffering typical Ménière's syndrome with incapacitating vertigo resistant to medical treatment. The follow-up time exceeds 2 years for all cases. It ranges from 2 to 4 years with an average of 2.5 years. This treatment had no effect on drop attacks. Also, hearing loss does not seem to be influenced. The presence of a transtympanic ventilation tube has not caused any major complications in these patients. Obstruction or loss of the tube was in some cases followed by the reappearance of vertigo. It is therefore important to check the patency of the tube before concluding that treatment has failed. The apparent benefit of ventilation tubes in reducing the occurrence of vertiginous attacks suggests that patients with endolymphatic hydrops are particularly sensitive to middle ear pressure.
Montandon
P
P
Clinic of Otolaryngology, Head and Neck Surgery, Cantonal University Hospital, Geneva, Switzerland.
Guillemin
P
P
Häusler
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D004487:Edema / Q000150:complications; D004712:Endolymphatic Sac; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007759:Labyrinth Diseases / Q000150:complications; D008297:Male; D008575:Meniere Disease / Q000150:complications / Q000601:surgery*; D008875:Middle Aged; D008876:Middle Ear Ventilation; D014717:Vertigo / Q000517:prevention & control*